Bridgewater Associates LP Has $4.32 Million Stock Position in Henry Schein, Inc. (NASDAQ:HSIC)

Bridgewater Associates LP lowered its position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 61.2% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 59,254 shares of the company's stock after selling 93,492 shares during the quarter. Bridgewater Associates LP's holdings in Henry Schein were worth $4,320,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Cromwell Holdings LLC increased its stake in Henry Schein by 93.4% in the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company's stock valued at $26,000 after buying an additional 170 shares during the period. Summit Securities Group LLC acquired a new position in Henry Schein in the 2nd quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA acquired a new position in Henry Schein in the 2nd quarter valued at approximately $37,000. Blue Trust Inc. increased its stake in Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock valued at $60,000 after buying an additional 475 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in Henry Schein by 58.9% in the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company's stock valued at $68,000 after buying an additional 346 shares during the period. Institutional investors and hedge funds own 96.62% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on HSIC. Evercore ISI increased their price target on shares of Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. Barrington Research restated an "outperform" rating and set a $82.00 price target on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com upgraded shares of Henry Schein from a "sell" rating to a "hold" rating in a research note on Thursday, November 7th. JPMorgan Chase & Co. dropped their price target on shares of Henry Schein from $88.00 to $80.00 and set an "overweight" rating on the stock in a research note on Monday, August 12th. Finally, Robert W. Baird dropped their price target on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a research note on Wednesday, August 7th. Six investment analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $79.38.

Insider Buying and Selling at Henry Schein

In other news, COO Michael S. Ettinger sold 12,240 shares of the firm's stock in a transaction dated Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the completion of the transaction, the chief operating officer now directly owns 87,706 shares of the company's stock, valued at approximately $6,577,950. This trade represents a 12.25 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the transaction, the senior vice president now directly owns 71,833 shares of the company's stock, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.14% of the company's stock.

Henry Schein Stock Performance

Shares of NASDAQ HSIC traded down $0.61 during trading hours on Friday, hitting $77.05. 608,569 shares of the stock were exchanged, compared to its average volume of 1,397,171. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company's 50 day moving average is $71.48 and its 200 day moving average is $69.92. The firm has a market capitalization of $9.61 billion, a P/E ratio of 31.71, a P/E/G ratio of 2.23 and a beta of 0.87. Henry Schein, Inc. has a one year low of $63.67 and a one year high of $82.63.

Henry Schein (NASDAQ:HSIC - Get Free Report) last posted its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.17 by $0.05. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. During the same period in the prior year, the firm earned $1.32 EPS. Henry Schein's quarterly revenue was up .4% compared to the same quarter last year. On average, research analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.